Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedA dedicated Locations section and listed sites (Kansas, Pennsylvania, Texas, Washington) were added, reorganizing location information for the study.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision history updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe general funding/operating status notice was removed, while the study details remain unchanged.SummaryDifference0.4%

- Check53 days agoChange DetectedThe new screenshot shows only formatting and UI adjustments; core study details (title, conditions, inclusion/exclusion criteria, interventions, and outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedIntroducing a major version upgrade to v3.2.0 and a government operating-status notice; removing the previous v3.1.0 reference. This indicates a new release with potentially updated functionality and critical status information for users.SummaryDifference3%

- Check89 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0; previous version tag removed and new version tag added.SummaryDifference0.1%

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.